Digital BIOmarkers for the Assessment of Motor Status in Parkinson's Disease Patients with CLInical and ThErapeutic Application
Launched by UNIVERSIDAD POLITECNICA DE MADRID · Feb 4, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The participants must perform a set of exercises related to the MDS-UPDRS III scale and some free-living activities. These tasks must be performed wearing a smartwatch.
The activities will be done in supervised clinical and unsupervised free-living environments. The participants must perfom a baseline and a final assesment in supervised conditions and a week of free living monitoring.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of Parkinson's disease based on the UK Brain Bank criteria.
- • Affiliated with Asociación Parkinson Madrid.
- • Minimal or mild disease severity, defined by a Hoehn and Yahr scale score of ≤ 2.5.
- • Be capable of performing the prescribed exercises independently.
- • Maintain daily functioning without dependence on caregivers.
- Exclusion Criteria:
- • Hoehn and Yahr scale score of \> 2.5.
- • Have undergone deep brain stimulation, used dopamine infusion pumps, or have conditions mimicking PD symptoms (e.g., progressive supranuclear palsy, Lewy body dementia, multiple system atrophy, or other parkinsonian syndromes)
- • Experience motor symptom fluctuations throughout the day.
About Universidad Politecnica De Madrid
The Universidad Politécnica de Madrid (UPM) is a leading institution in engineering and technology education, renowned for its commitment to innovation and research excellence. As a clinical trial sponsor, UPM leverages its interdisciplinary expertise to advance medical research and develop novel therapeutic solutions. The university fosters collaborations with healthcare professionals, industry partners, and research organizations to conduct rigorous clinical studies that aim to improve patient outcomes and contribute to the scientific community. With a strong emphasis on ethical practices and regulatory compliance, UPM is dedicated to enhancing the landscape of clinical research through its robust academic framework and cutting-edge facilities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported